Literature DB >> 19242514

The effect of having an affected parent or sibling on invasive and in situ skin cancer risk in Sweden.

Shehnaz K Hussain1, Jan Sundquist, Kari Hemminki.   

Abstract

Studies suggest that skin cancer aggregates within families; however, the risk of skin cancer associated with having an affected sibling or parent by subtype, tumor site, and age at diagnosis has not been established. The 2006 update of the Swedish Family-Cancer Database was used to calculate standardized incidence ratios (SIRs), representing the ratio of cancer risk among individuals with affected parents or siblings to the general population. Risk of invasive squamous cell skin cancer for individuals with an affected sibling or parent was increased between two- and three-fold compared with that in the general population. For in situ skin tumors, increased SIRs of 1.95-4.30 for squamous cell, Bowen's disease, and actinic keratosis were observed for individuals with affected siblings or parents, and SIRs were generally higher for tumors at sun-exposed versus covered sites. Finally, SIRs for in situ and invasive squamous cell skin cancer increased by increasing number of parental tumors (P< or =0.01). In conclusion, having an affected sibling or parent was associated with an increased risk of skin cancer of varied subtypes compared with that in the general population, and for some subtypes, these familial risks were increased for tumors at sun-exposed sites or by an increasing number of parental tumors.

Entities:  

Mesh:

Year:  2009        PMID: 19242514     DOI: 10.1038/jid.2009.31

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Management of a cutaneous squamous cell carcinoma overlying an AV fistula.

Authors:  Neel Som Nath; Brian F Gilmore; Richard K McCann; Paul J Mosca
Journal:  BMJ Case Rep       Date:  2017-05-06

2.  Family history of skin cancer is associated with increased risk of cutaneous squamous cell carcinoma.

Authors:  Maryam M Asgari; E Margaret Warton; Alice S Whittemore
Journal:  Dermatol Surg       Date:  2015-04       Impact factor: 3.398

3.  Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk.

Authors:  Joanne E Sordillo; Peter Kraft; Ann Chen Wu; Maryam M Asgari
Journal:  J Invest Dermatol       Date:  2018-02-13       Impact factor: 8.551

4.  Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.

Authors:  Maryam M Asgari; Wei Wang; Nilah M Ioannidis; Jacqueline Itnyre; Thomas Hoffmann; Eric Jorgenson; Alice S Whittemore
Journal:  J Invest Dermatol       Date:  2016-01-29       Impact factor: 8.551

5.  Comparison of Familial Clustering of Anogenital and Skin Cancers Between In Situ and Invasive Types.

Authors:  Luyao Zhang; Otto Hemminki; Guoqiao Zheng; Asta Försti; Kristina Sundquist; Jan Sundquist; Kari Hemminki
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

6.  Predicting keratinocyte carcinoma in patients with actinic keratosis: development and internal validation of a multivariable risk-prediction model.

Authors:  S Tokez; M Alblas; T Nijsten; L M Pardo; M Wakkee
Journal:  Br J Dermatol       Date:  2020-02-26       Impact factor: 9.302

7.  Identifying Susceptibility Loci for Cutaneous Squamous Cell Carcinoma Using a Fast Sequence Kernel Association Test.

Authors:  Manyan Huang; Chen Lyu; Xin Li; Abrar A Qureshi; Jiali Han; Ming Li
Journal:  Front Genet       Date:  2021-05-10       Impact factor: 4.599

8.  Relation of statin use with non-melanoma skin cancer: prospective results from the Women's Health Initiative.

Authors:  Ange Wang; Marcia L Stefanick; Kristopher Kapphahn; Haley Hedlin; Manisha Desai; Jo Ann E Manson; Howard Strickler; Lisa Martin; Jean Wactawski-Wende; Michael Simon; Jean Y Tang
Journal:  Br J Cancer       Date:  2016-01-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.